C28H30N2O2
Neat
426.56
Room Temperature
Darifenacin; 133099-04-4; UK-88525; 2-[(3S)-1-[2-(2, 3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2, 2-diphenylacetamide; darifenacine; Darifenacina; Darifenacin extended release; APG9819VLM; UK88525; (S)-1-(2-(2, 3-Dihydro-5-benzofuranyl)ethyl)-alpha, alpha-diphenyl-3-pyrrolidineacetamide; DTXSID2048290; CHEBI:391960; 2-{(3S)-1-[2-(2, 3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2, 2-diphenylacetamide; 3-Pyrrolidineacetamide, 1-(2-(2, 3-dihydro-5-benzofuranyl)ethyl)-alpha, alpha-diphenyl-, (3S)-; darifenicin; Darifenacinum; 2-((3S)-1-(2-(2, 3-dihydro-1-benzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2, 2-diphenylacetamide; 2-((3S)-1-(2-(2, 3-dihydro-1-benzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2, 2-di(phenyl)acetamide; 2-[(3S)-1-[2-(2, 3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2 and 2-di(phenyl)acetamide; RefChem:57150
2-[(3S)-1-[2-(2, 3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2 and 2-diphenylacetamide
InChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1